Heterogeneity of O6-alkylguanine-DNA-alkyltransferase measured by flow cytometric analysis in blood and bone marrow mononuclear cells

Clinical Cancer Research

Volumn 4, Issue 2, 1998, Pages 475-481

  Liu, Lili ^a   Lee, Keunmyoung ^a   Schupp, Jane ^a   Koç, Omer N ^a   Gerson, Stanton L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; DRUG DERIVATIVE; GUANINE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MONOCLONAL ANTIBODY; O(6) BENZYLGUANINE; O(6)-BENZYLGUANINE;

ALKYLATION; ARTICLE; BONE MARROW CELL; CELL SUSPENSION; CYTOTOXICITY; DNA ADDUCT; ENZYME ACTIVITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CONTENT; ANIMAL; BLOOD; CELL MEMBRANE PERMEABILITY; CELL SEPARATION; CHO CELL; ENZYME ACTIVATION; ENZYMOLOGY; HAMSTER; METABOLISM; METHODOLOGY; SENSITIVITY AND SPECIFICITY; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, WESTERN; BONE MARROW CELLS; CELL MEMBRANE PERMEABILITY; CELL SEPARATION; CHO CELLS; CRICETINAE; ENZYME ACTIVATION; FLOW CYTOMETRY; GUANINE; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; SENSITIVITY AND SPECIFICITY;

EID: 0031594261     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. 6-alkylguanine-DNA AGT. Science (Washington DC), 259: 219-222, 1993.
2. 6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA, 87: 5368-5372, 1990.
3. 6-methylguanine-DNA adducts protects transgenic mice from N-methylnitrosourea-induced thymic lymphomas. Cancer Res., 54: 4648-4652, 1994.
4. 6-methylguanine-DNA methyltransferase expression in Mer+ human tumor cells. Carcinogenesis (Lond.), 16: 2255-2257, 1995.
5. 6-alkylguanine-DNA AGT: regulation and importance in response to alkylating carcinogenic and therapeutic agents. Cancer Res., 50: 6119-6129, 1990.
6. 6-alkylguanine-DNA AGT. Prog. Nucleic Acid Res. Mol. Biol., 51: 167-223, 1995.
7. 6-alkylguanine and its repair and their application to studies of the molecular epidemiology of this lesion in human populations. IARC Sci. Publ., 105: 78-82, 1991.
8. 6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restrictive endonuclease inhibition. Cancer Res., 47: 6229-6235, 1987.
9. 6-alkylguanine-DNA AGT activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis (Lond.), 7: 745-749, 1986.
10. 6-benzylguanine using a transgenic model. Cancer Res., 56: 1880-1885, 1996.
11. 6-alkylguanine-DNA AGT using newly developed monoclonal antibodies. Cancer Res., 50: 58-61, 1990.
12. Allay, J. A., Dumenco, L. L., Liu, L., and Gerson, S. L. Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood, 85: 3342-3351, 1995.
13. 6-Alkylguanine-DNA alkyltransferase: a target for the modulation of drug resistance. Hematol./ Oncol. Clin. N. Am., 2: 431-450, 1995.
14. 6-benzylguanine and BCNU. Cancer Res., 57: 5093-5099, 1997.
15. 6-Alkylguanine-DNA alkyltransferase activity in human myeloid cells. J. Clin. Invest., 76: 2106-2114, 1985.
16. 6-benzylguanine plus BCNU. Blood, 88: 1649-1655, 1996.
17. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry, 35: 1328-1334, 1996.
18. 6-alkylguanine-DNA alkyltransferase activity in human colon cancer. Clinical Cancer Res., 1: 519-525, 1995.
19. 6-methylguanine-DNA methyltransferase and its possible application for monitoring human exposure to alkylating carcinogens. Cancer Res., 54: 3726-3721, 1994.
20. 6-methylguanine-DNA methyltransferase activity and mRNA levels in HT-29 cells in vitro. Cancer Res., 51: 1581-1585, 1991.